Stock Evaluator: Clover Health Investments, Corp. (CLOV)

Clover Health Investments, Corp. CLOV

$3.73 -0.04 -1.06%
November 20, 2026 4:00:01 PM EST November 10, 2021 Volume: 7,237,920
After Hours: $120.37   0.15  |  0.12% November 10, 2021 7:59 PM EST Volume: 72,713
USD NASD | DELAYED PRICE
SECTOR INDUSTRY
Health Care Health Care Providers & Services

A+ Stock Grade Summary:

VALUE:
GROWTH:
MOMENTUM:
EPS REVISIONS:
QUALITY:
COMPANY SUMMARY
Clover Health Investments, Corp. provides medicare advantage plans in the United States. The company offers preferred provider organization and health maintenance organization plans to medicare-eligible individuals. It also operates Clover Assistant, a software platform for physicians to detect, identify, and manage chronic diseases. The company was founded in 2014 and is based in Wilmington, Delaware.

Commentary & Analysis


Financial Summary

Share Statistics CLOV Industry
Median
Percentile
(All Stocks)
Market Cap (Mil) $1,997.1 $1,721.2 56%
Shares Out (Mil) 557.5 80.6 89%
Institutional Ownership 57.3% 87.6% 38%
Float (Mil) 416.7 59.2 83%
Beta 2.48 0.74 96%
Avg Daily Volume (000s) 5,664 613 93%
Price Change
(52-week)
60.8% 74.5% 91%
Growth CLOV Industry
Median
Percentile
(All Stocks)
Sales (5yr) 22.8% 10.4% 84%
Net Income (5yr) 8.9% (0.5%) 53%
EPS (5yr) 35.9% 3.0% 86
Dividends (5yr) 0.0% 0.0% 0%
Cash Flow (5yr) (23.1%) (17.4%) 28%
Estimates Qtrly Current
Fiscal
Year
Next
Fiscal
Year
# of Estimates 1 1 1
Current EPS ($0.030) $0.140 $0.180
Month Ago EPS ($0.020) $0.140 $0.150
# Rev Up 0 1 0
# Rev Down 1 0 0
Three Months Ago EPS ($0.020) $0.140 $0.150
Year/Year Chg (400.0%) (183.8%) (243.7%)
Financials CLOV Industry
Median
Percentile
(All Stocks)
Sales (TTM) (Mil) $2,739 $1,529 64%
Net Income (TTM) (Mil) $13 $33 46%
EPS (TTM) $0.024 $0.300 40%
Operating Cash Flow (TTM) (Mil) $135 $175 54%
Net Cash Flow (TTM) (Mil) $78 $7 74%
Long-Term Debt (Q1) (Mil) $0 $419 0%
Enterprise Value (Q1) (Mil) $2,313 $2,427 51%
Valuation CLOV Industry
Median
Percentile
(All Stocks)
P/B 5.11 2.56 83%
P/E 186.5 25.9 98%
Dividend Yield 0.0% 0.0% 0%
PEG (5yr hist) 5.2 1.1 89%
Ratios CLOV Industry
Median
Percentile
(All Stocks)
Gross Margin 18.9% 27.3% 19%
Net Margin 0.5% 1.4% 32%
ROA 1.9% 2.4% 54%
ROE 3.4% 7.3% 39%
Liabilities to Assets 48.1% 62.3% 40%
F-Score 5 5 50%

Passing Stock Screens

As of 11/20/2026, from a list of 60 stock screening strategies, CLOV meetings the criteria of 1 screen:

Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.

Ⓒ 2026 American Association of Individual Investors